New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
12:38 EDTRENN, FSLR, HZNP, ORCL, OWW, FDXOn The Fly: Midday Wrap
Stocks on Wall Street were virtually unchanged at midday as investors await the latest rate decision and associated policy updates from the Federal Reserve. The market spent the morning consolidating its recent gains and stocks moved in a very narrow range since the open. Rates are expected to remain the same and Treasury purchases are expected to be reduced again. Investors and analysts will be paying close attention to the accompanying statement and press conference for clues as to any change in monetary policy. ECONOMIC EVENTS: In the U.S., the fourth quarter current account deficit narrowed to $81.1B, which lower than expected and down from a revised Q3 deficit of $96.4B. Investors await the FOMC meeting announcement, due at 2:00 pm ET, to be followed by Fed Chairwoman Janet Yellen’s press conference at 2:30 pm ET. COMPANY NEWS: Delivery giant FedEx (FDX) reported lower than expected third quarter revenue and earnings per share and lowered its FY14 outlook. Shares were down in pre-market trading but have bounced back to be up just slightly near midday as investors appear to be attributing the earnings miss to the severe winter weather, as the company explained... Another giant corporation, Oracle (ORCL), reported headline earnings and revenue for its last quarter than missed consensus expectations and its shares were down about 1% in midday trading. However, analysts at firms including Wells Fargo, Susquehanna and Stifel argued Oracle's underlying results were better than the headlines and contended the weakness was a buying opportunity. MAJOR MOVERS: Among the notable gainers was Horizon Pharma (HZNP), which advanced 14% after agreeing to buy Vidara Therapeutics through a reverse merger for stock and cash valued at about $660M to create a new company that will be organized under the laws of Ireland. Also higher was First Solar (FSLR), which jumped 14% after the company gave an earnings outlook for the current fiscal year that missed expectations but also guided to significantly better than expected earnings next fiscal year. Among the noteworthy losers after its earnings report was Renren (RENN), which operates a real name social networking Internet platform in China. The company's headline earnings beat the consensus forecast, but that was primarily due to a gain from the deconsolidation of its subsidiaries, and its shares dropped 10% following the report. Also lower was online travel company Orbitz Worldwide (OWW), which fell 9% after Goldman downgraded the stock to a Sell rating from Neutral. INDEXES: Near midday, the Dow was down 5.81, or 0.04%, to 16,330.38, the Nasdaq was down 4.41, or 0.1%, to 4,328.90, and the S&P 500 was down 0.52, or 0.03%, to 1,871.73.
News For FDX;ORCL;FSLR;OWW;HZNP;RENN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 23, 2015
14:34 EDTFDXFedEx CEO says would do business in Iran if permitted
Subscribe for More Information
14:30 EDTFDXFedEx CEO feels Fed shoud raise rates this year
Subscribe for More Information
06:32 EDTORCLOracle requests permission to update suit against Google, Reuters reports
Oracle (ORCL) has requested permission from a U.S. judge to update its copyright lawsuit against Google (GOOG) to include the Android operating system's current market dominance, Reuters reports. Oracle has said it wants the suit to add that Google continues its copyright infringement through updated versions of Android, the report says. Reference Link
July 21, 2015
17:41 EDTFDXFedEx to acquire fifty additional 767-300F aircraft from Boeing
Subscribe for More Information
14:24 EDTORCLEarnings Watch: EMC reports amid M&A speculation in sector
Subscribe for More Information
11:28 EDTHZNPDepomed says revised Horizon proposal includes no change to amount of stock
Depomed (DEPO) confirmed that it has received a "purported revised, highly conditional, unsolicited and non-binding" proposal from Horizon Pharma (HZNP) to acquire all of the outstanding shares of Depomed in an all-stock transaction currently valued at $33.00 per share. Depomed said its board, in consultation with its independent financial and legal advisors, will carefully review and evaluate the revised proposal to determine the course of action that it believes is in the best interests of the company and its shareholders. Depomed added: "Today's purported increase does not reflect any increase in the amount of Horizon stock that the Depomed shareholders would receive, nor any increase in the pro-forma ownership for the Depomed shareholders, and is the result of the trading value of Horizon's stock having increased since it made its initial offer." Depomed previously rejected the prior proposal, made May 27, to acquire all outstanding common shares of Depomed in an all-stock transaction then valued at $29.25 per share.
07:15 EDTORCLOracle management to meet with Deutsche Bank
Subscribe for More Information
07:02 EDTHZNPHorizon Pharma increases offer for Depomed to $33.00 per share
Horizon Pharma (HZNP) announced that it has increased the value of its all-stock acquisition proposal to $33.00 per share from $29.25 per share, contingent on Depomed entering into good faith discussions regarding a transaction. The increased offer represents a 60% premium to the closing price of Depomed on July 6, the day prior to when Horizon's initial proposal was made public.
07:01 EDTHZNPHorizon Pharma increases offer for Depomed to $33.00 per share
July 20, 2015
10:33 EDTHZNPDepomed suitor Horizon Pharma advances after raising outlook
Subscribe for More Information
09:50 EDTHZNPHorizon Pharma CEO says 'here to stick it out' regarding Depomed deal
Subscribe for More Information
09:50 EDTHZNPHorizon Pharma CEO says Depomed proposal 'shareholder friendly'
Subscribe for More Information
09:22 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
07:16 EDTHZNPHorizon Pharma up 5.2% after reporting preliminary Q2 revenue, raises FY15 view
Subscribe for More Information
07:07 EDTORCLOracle management to meet with Deutsche Bank
Meetings to be held in Montreal/Toronto on July 20 hosted by Deutsche Bank.
07:07 EDTOWWOrbitz rewards program exceeds 4M members
Subscribe for More Information
07:05 EDTHZNPHorizon Pharma raises FY15 revenue guidance to $660M-$680M from $590M-$610M
Consensus $611.6M. Raises FY15 adjusted EBITDA guidance to $265M-$280M from $235M-$250M.
07:04 EDTHZNPHorizon Pharma sees Q2 revenue $170M-$172M, consensus $138.26M
July 17, 2015
11:16 EDTFDXFedEx spikes higher, levels to watch
Subscribe for More Information
11:07 EDTFDXRumor: FedEx moves up on activist investor speculation
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use